CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
8.80
+0.33 (3.90%)
Jul 2, 2026, 11:37 AM EDT - Market open
CorMedix Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 387.18 | 311.71 | 43.47 | - | 0.07 | 0.19 | |
Revenue Growth (YoY) | 369.00% | 617.03% | - | - | -65.74% | -20.19% |
Cost of Revenue | -4.44 | -22.09 | -3.03 | - | 0 | 0.15 |
Gross Profit | 37.87 | 275.75 | 40.28 | - | 0.06 | 0.04 |
Selling, General & Admin | -154.69 | -106.27 | -58.7 | 35.8 | 20.01 | 16.35 |
Research & Development | -29.74 | -19.33 | -3.94 | 13.16 | 10.68 | 13.13 |
Total Operating Expenses | -184.43 | -125.61 | -62.64 | 48.96 | 30.69 | 29.48 |
Operating Income | 193.67 | 150.14 | -22.36 | -48.96 | -30.62 | -29.44 |
Interest Income | 3.28 | 3.85 | 2.58 | 2.68 | 0.33 | 0.01 |
Interest Expense | -2.77 | -2.78 | -0.04 | -0.03 | -0.03 | -0.02 |
Other Non-Operating Income (Expense) | -0.28 | -1.19 | 0.49 | -0.03 | 0.04 | -0.02 |
Total Non-Operating Income (Expense) | -8.66 | -0.13 | 3.03 | 2.62 | 0.34 | -0.02 |
Pretax Income | 108.22 | 150.02 | -19.33 | -46.34 | -30.29 | -29.46 |
Provision for Income Taxes | -4.01 | 13.04 | 1.4 | - | -0.59 | -1.25 |
Net Income | 181.01 | 163.06 | -17.93 | -46.34 | -29.7 | -28.21 |
Net Income to Common | 181.01 | 163.06 | -17.93 | -46.34 | -29.7 | -28.21 |
Net Income Growth | 953.61% | - | - | - | - | - |
Shares Outstanding (Basic) | 76 | 72 | 59 | 51 | 40 | 38 |
Shares Outstanding (Diluted) | 86 | 80 | 59 | 51 | 40 | 38 |
Shares Change (YoY) | 37.63% | 36.41% | 15.65% | 26.39% | 6.93% | 31.87% |
EPS (Basic) | 2.37 | 2.25 | -0.30 | -0.91 | -0.74 | -0.75 |
EPS (Diluted) | 2.13 | 2.04 | -0.30 | -0.91 | -0.74 | -0.75 |
EPS Growth | 965.00% | - | - | - | - | - |
Free Cash Flow | 194.71 | 172.79 | -50.73 | -38.74 | -24.58 | -22.58 |
Free Cash Flow Growth | 12.69% | - | - | - | - | - |
Free Cash Flow Per Share | 2.26 | 2.15 | -0.86 | -0.76 | -0.61 | -0.60 |
Gross Margin | 9.78% | 88.46% | 92.66% | - | 94.29% | 22.00% |
Operating Margin | 50.02% | 48.17% | -51.43% | - | -46819.90% | -15417.50% |
Profit Margin | 46.75% | 52.31% | -41.24% | - | -45409.90% | -14774.70% |
FCF Margin | 50.29% | 55.43% | -116.70% | - | -37573.50% | -11826.20% |
EBITDA | 219 | 165.53 | -21.9 | -48.75 | -30.41 | -29.26 |
EBITDA Margin | 56.56% | 53.10% | -50.37% | - | -46500.30% | -15324.80% |
EBIT | 193.67 | 150.14 | -22.36 | -48.96 | -30.62 | -29.44 |
EBIT Margin | 50.02% | 48.17% | -51.43% | - | -46819.90% | -15417.50% |
Effective Tax Rate | -3.70% | 8.69% | -7.22% | 0.00% | 1.93% | 4.24% |